
About us - Schrödinger
Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered.
Computational Platform for Molecular Discovery & Design - Schrödinger
Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space.
Schrödinger
4 days ago · Contact us: Please reach out to [email protected] for questions pertaining to the application process or science fair.
Schrödinger Announces Discontinuation of SGR-2921 Program
Aug 14, 2025 · Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, …
Pipeline of Collaborative & Proprietary Drug Discovery Programs ...
We are leveraging our computational platform and massive computing power to advance our proprietary programs both independently and in collaboration with leading biotech and pharmaceutical companies.
Schrödinger, Inc. - Investor Relations
Dec 17, 2025 · Schrödinger is transforming the way therapeutics and materials are discovered. Learn more about our company.
Life science - Schrödinger
Maximize your creativity with the industry-leading computational platform for molecular design, discovery, and collaboration.
Materials science - Schrödinger
Our molecular modeling platform enables the prediction of better properties for better materials for a wide array of industries, including aerospace, energy, semiconductors, and electronic displays.
Our Team - Schrödinger
Schrödinger’s collaborative leadership team is committed to achieving the best possible outcomes for our customers, partners, patients, and other stakeholders.
Schrödinger - 分子の発見と設計のための物理ベースのソフトウェア
Dec 17, 2025 · 難溶性薬物の放出メカニズムを解明する – ASD研究の新たなアプローチ | Modelling amorphous solid dispersion (ASD) release mechanisms OCT 15, 2025 | AbbVie と Schrödinger のエ …